News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX)'s Bausch & Lomb Gets $39.5 Million From New Jersey To Move HQs



12/13/2013 8:03:39 AM

Valiant isn't the only one hiring, others are hiring too! Check it out! (Isn't it tempting?)

New Jersey economic development officials are giving Valeant Pharmaceuticals International Inc. $39.5 million to put its U.S. headquarters in the Garden State. Valeant completed an $8.7 billion acquisition of Bausch & Lomb in August. The pharmaceuticals firm said it would make the Rochester-based Bausch & Lomb the core of its eye-health business. But even before the deal closed, the Quebec company’s CEO, Michael Pearson, announced plans to make New Jersey Valeant’s U.S. eye-health base.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES